Get the Stockscreener App
10.08
1.18%
-0.1207
Daxor Corporation stock is traded at $10.08, with a volume of 871.
It is down -1.18% in the last 24 hours and down -4.01% over the past month.
Daxor Corporation, a medical device company, provides biotechnology and cryobanking services in the United States. The company offers BVA-100 Blood Volume Analyzer, an instrument that measures blood volume in human body. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients in various medical and surgical conditions, including congestive heart failure, critical care medicine and intensive care unit medicine, hypertension, syncope, pre-operative blood screening for hidden anemia, anemia in cancer patients, kidney failure, and hyponatremia. It also provides semen banking, blood storage, andrology, and general lab testing services. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.
See More
Previous Close:
$10.20
Open:
$9.9001
24h Volume:
871
Relative Volume:
0.22
Market Cap:
$58.85M
Revenue:
$503.40K
Net Income/Loss:
$9.17M
P/E Ratio:
5.5659
EPS:
1.8109
Net Cash Flow:
$-604.40K
1W Performance:
+0.79%
1M Performance:
-4.01%
6M Performance:
-15.01%
1Y Performance:
-8.37%
1-Day Range:
$9.9001
$10.08
1-Week Range:
$9.5501
$10.62
52-Week Range:
$8.56
$14.76
Daxor Corporation Stock (DXR) Company Profile
Name
Daxor Corporation
Sector
Industry
Phone
212-330-8500
Address
Empire State Building, Suite 7120 350 Fifth Avenue, New York, NY
Compare DXR vs ISRG, BDX, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DXR
Daxor Corporation
|
10.08 | 60.13M | 503.40K | 9.17M | -604.40K | 1.8109 |
ISRG
Intuitive Surgical Inc
|
376.86 | 132.30B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
188.11 | 51.11B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
72.06 | 35.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
240.10 | 32.95B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
35.03 | 28.58B | 29.14B | 1.07B | 1.05B | 1.1956 |
Daxor Corporation Stock (DXR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-16-19 | Initiated | Ascendiant Capital Markets | Buy |
Daxor Corporation Stock (DXR) Latest News
Why Is Daxor (NASDAQ:DXR) in Focus Today? - Kalkine Media
What Could Daxor (NASDAQ:DXR) Reveal Today About Its Next Operating Milestones? - Kalkine Media
Daxor (DXR) Price and Levels: Moves 0.95% Up to $10.30 for the Current Session; Technical Position - dars.gov.et
Daxor Corporation (DXR) Holds Steady at $10.2 as Trading Range NarrowsRetail Sentiment - vinanet.vn
Liquidity Mapping Around (DXR) Price Events - Stock Traders Daily
Daxor Corporation (NASDAQ:DXR) Short Interest Update - MarketBeat
Daxor Corp (DXR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Daxor Corp (DXR) Stock News Today - TradingKey
Why (DXR) Price Action Is Critical for Tactical Trading - Stock Traders Daily
DXR Q3 2007 Earnings: EPS of $0.43 Blows Past Estimates in 325.7% UpsetAnalyst Drop Coverage - vinanet.vn
Daxor Launches Blood Testing Lab in Eastern Kansis - marketscreener.com
Daxor Corporation Initiates Outpatient Blood Volume Analysis Program in Kansas - marketscreener.com
Daxor Corporation Launches Outpatient Blood Volume Analysis Program at Kansas Healthcare Facility - Quiver Quantitative
Daxor Launches New Blood Volume Analysis Program - Intellectia AI
Daxor Broadens Outpatient Footprint with Initiation of ezBVA Lab Diagnostic Services in Kansas - GlobeNewswire
Daxor Corp (DXR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
DXR|Daxor Corp|Price:11.050|Chg%:+0.600 - TradingKey
Daxor Corp (DXR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Daxor Corp (DXR) Balance Sheet - TradingKey
Daxor Corp (DXR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Daxor Corp (DXR) Earnings Date & Reports & Earnings News - TradingKey
Daxor Corp (DXR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Daxor Corporation Declines 3.77%: Support Levels in FocusRevenue Growth Stocks - dars.gov.et
Daxor Corp (DXR) Institutional Confidence - TradingKey
Daxor Corp (DXR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
DXR|Daxor Corp|Price:9.800|Chg%:-0.403 - TradingKey
Daxor Corporation (DXR) Slips 2.38% as Stock Nears Key SupportBollinger Squeeze - dars.gov.et
Daxor Corp (DXR) Cash Flow - TradingKey
Daxor Corporation (DXR) Holds Steady Near Support in Tight Trading RangeHigh Volume Stocks - vinanet.vn
Daxor (DXR) Proxy filing Summary - Quartr
Understanding Momentum Shifts in (DXR) - Stock Traders Daily
DXR Q3 2007 Earnings: EPS Surges 325.7% Above EstimatesEarnings Growth Forecast - Vinanet
DXR Q3 2007 Earnings: EPS Surges 325% Above Estimates, Driving Strong Stock AppreciationEPS Growth Report - vinanet.vn
Daxor to exhibit blood volume analyzer at dysautonomia conference By Investing.com - Investing.com Nigeria
Daxor to exhibit blood volume analyzer at dysautonomia conference - Investing.com
Daxor Corporation Announces First-Time Exhibition at the 14th Annual Dysautonomia International Conference in The Woodlands, Texas - The Manila Times
Daxor Corporation Announces First-Time Exhibition at the - GlobeNewswire
Daxor debuts Blood Volume Analyzer at Dysautono... - Pluang
DXR Q3 2007 Earnings: EPS Surges 326% Above Estimates, Stock Climbs $1.44Earnings Miss Alert - DonanımHaber
DXRDaxor Corp Options - Finviz
DXR Q3 2007 Earnings: Massive EPS Surprise of 325.7% on Reported Earnings of $0.43Quarterly Earnings - DonanımHaber
Avoiding Lag: Real-Time Signals in (DXR) Movement - Stock Traders Daily
Daxor Corporation (DXR) Edges Higher, Testing Key Resistance ZoneAdvance Decline Volume - dars.gov.et
Enterprise value to EBITDA forward of Daxor Corporation – NASDAQ:DXR - TradingView
Price to sales forward of Daxor Corporation – FWB:DX5 - TradingView
Price to book forward of Daxor Corporation – FWB:DX5 - TradingView
Enterprise value to revenue forward of Daxor Corporation – NASDAQ:DXR - TradingView
Enterprise value to EBIT forward of Daxor Corporation – NASDAQ:DXR - TradingView
Price to earnings forward of Daxor Corporation – NASDAQ:DXR - TradingView
Price to sales forward of Daxor Corporation – NASDAQ:DXR - TradingView
Enterprise value to EBITDA forward of Daxor Corporation – FWB:DX5 - TradingView
Daxor Corporation Stock (DXR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Daxor Corporation Stock (DXR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Michel Robert J | Chief Financial Officer |
Mar 31 '26 |
Buy |
9.90 |
1,000 |
9,900 |
21,050 |
1.40%
0.50%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):